WealthCollab’s Quest Diagnostics DGX Stock Holding History

WealthCollab’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-37	Closed	-$5.1K	–	878
2023 Q4	$5.1K	Buy	+37	New	+$4.86K	﹤0.01%	574

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WealthCollab's DGX Position: Q1 2024 in Review

WealthCollab sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 37 shares — an estimated $5.1K sold.

WealthCollab first reported a position in DGX in Q4 2023 and held it in 1 quarter. The position peaked at $5.1K in Q4 2023. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

WealthCollab reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
WealthCollab sold 37 Quest Diagnostics shares in Q1 2024, an estimated $5.1K.
WealthCollab first reported a position in Quest Diagnostics in Q4 2023 and held it in 1 quarter.
WealthCollab's Quest Diagnostics position peaked at $5.1K in Q4 2023.
818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on WealthCollab's 13F filing for Q1 2024, filed 10 May 2024.